Deranged hembiosynthetic pathway in gasoline dispensers in Nigeria: Implications for risk of myeloproliferative disorders and chemoprevention
American Journal of Biopharmacy and Pharmaceutical Sciences · 2022
DOI: 10.25259/ajbps_10_2021 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Biopharmacy and Pharmaceutical Sciences, 2022. Verfasst von John Ibhagbemien Anetor und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Objectives
There is increasing exposure to petrochemicals, including benzene, particularly in the low and medium-income countries. Benzene is a component of many petrochemicals and a ubiquitous environmental pollutant. Phenol is one of its principal metabolites and serves as a biomarker of exposure to benzene. The mechanism of its toxicity is incompletely elucidated. Benzene’s interaction with key micronutrients; copper (Cu), iron (Fe), and zinc (Zn) in the haemopoietic system has only been poorly explored, particularly in the developing countries where their status is variable and uncertain, with attendant intense exposure to petrochemicals. Material and Methods: Two groups of 50 gasoline dispensers (GDs) and 50 non-occupationally exposed participants were selected from Oye Local Government Area, Nigeria. The duration of occupational exposure was 2–10 years. Serum levels of Cu, Fe, and Zn were determined using flame atomic absorption spectrophotometry while heme and phenol were determined by standard spectrophotometry.
Results
Phenol was significantly higher in GDs ( P = 0.000), compared to controls ( P < 0.05). The micronutrients, Cu, Fe, and Zn were all significantly decreased in GDs compared to controls ( P = 0.000 in all cases). Phenol and Fe demonstrated significant inverse correlation (r = −0.557, P = 0.00), while heme and Zn also exhibited inverse correlation respectively to phenol (r = −0.38, P = 0.01; r = −0.37, P = 0.01).
Conclusion
These data suggest intense perturbation of the haemopoietic system in GDs; likely from altered xenobiotic metabolism requiring heme in cytochrome P 450 ; cell cycle dysregulation, where Zn is pivotal, p53 suppression also dependent on Zn and oxidative stress all converging in haemopoietic dysregulation. Importantly, depression of these micronutrients implies potentiation of myelotoxicity and risk of myeloproliferation, probably arising from alterations in transcription, differentiation errors, genome instability, and derangement in cell signal transduction moderated by Zn; accentuating risk of myeloproliferation; suggesting a role for these micronutrients in chemoprevention. Understanding these events may be important in risk assessment, policy formulation, regulatory measures and chemoprevention in GDs and the general population.
Zitieren
APA
Anetor, J. I., Adigun, T. O., Bolajoko, E. B., Anetor, G. O., Orimadegun, B. E., Akiibinu, M. O., Igharo, G. O., Iyanda, A. A., Ademola-Aremu, O. O., & Uche, C. Z. (2022). Deranged hembiosynthetic pathway in gasoline dispensers in Nigeria: Implications for risk of myeloproliferative disorders and chemoprevention. American Journal of Biopharmacy and Pharmaceutical Sciences. https://doi.org/10.25259/ajbps_10_2021
Vancouver
Anetor JI, Adigun TO, Bolajoko EB, Anetor GO, Orimadegun BE, Akiibinu MO, et al. Deranged hembiosynthetic pathway in gasoline dispensers in Nigeria: Implications for risk of myeloproliferative disorders and chemoprevention. American Journal of Biopharmacy and Pharmaceutical Sciences. 2022. doi:10.25259/ajbps_10_2021
BibTeX
@article{Anetor2022,
author = {Anetor, John Ibhagbemien and Adigun, Temidayo Olamide and Bolajoko, Elizabeth Bosede and Anetor, Gloria Oiyahumen and Orimadegun, Bose Etaniamhe and Akiibinu, Moses Olayemi and Igharo, Godwin Osaretin and Iyanda, Ayobola Abolape and Ademola-Aremu, Oluwakemi O. and Uche, Chukwuemelie Zedech},
title = {Deranged hembiosynthetic pathway in gasoline dispensers in Nigeria: Implications for risk of myeloproliferative disorders and chemoprevention},
journal = {American Journal of Biopharmacy and Pharmaceutical Sciences},
year = {2022},
doi = {10.25259/ajbps_10_2021}
}
EUVIMED